Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.

Jarajapu YP, Hazra S, Segal M, Li Calzi S, Jadhao C, Qian K, Mitter SK, Raizada MK, Boulton ME, Grant MB.

PLoS One. 2014 Apr 8;9(4):e93965. doi: 10.1371/journal.pone.0093965. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103913. LiCalzi, Sergio [corrected to Li Calzi, Sergio]; Jhadao, Chandra [corrected to Jadhao, Chandra].

2.

CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.

Lee JH, Lee SH, Yoo SY, Asahara T, Kwon SM.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1622-34. doi: 10.1161/ATVBAHA.112.301052. Epub 2013 May 2.

3.

Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting.

Scheubel RJ, Holtz J, Friedrich I, Borgermann J, Kahrstedt S, Navarrete Santos A, Silber RE, Simm A.

Int J Cardiol. 2010 Mar 4;139(2):134-41. doi: 10.1016/j.ijcard.2008.10.009. Epub 2008 Nov 12.

PMID:
19008002
4.

Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia.

Capla JM, Grogan RH, Callaghan MJ, Galiano RD, Tepper OM, Ceradini DJ, Gurtner GC.

Plast Reconstr Surg. 2007 Jan;119(1):59-70.

PMID:
17255657
5.

The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration.

Grote K, Salguero G, Ballmaier M, Dangers M, Drexler H, Schieffer B.

Blood. 2007 Aug 1;110(3):877-85. Epub 2007 Apr 11.

6.

Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.

Bakhashab S, Ahmed FW, Schulten HJ, Bashir A, Karim S, Al-Malki AL, Gari MA, Abuzenadah AM, Chaudhary AG, Alqahtani MH, Lary S, Ahmed F, Weaver JU.

Cardiovasc Diabetol. 2016 Feb 9;15:27. doi: 10.1186/s12933-016-0344-2.

7.

Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity.

Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, Ito A, Liu T, Kamide C, Agrawal H, Perlman H, Qin G, Kishore R, Losordo DW.

Circ Res. 2011 Sep 16;109(7):724-8. doi: 10.1161/CIRCRESAHA.111.253286. Epub 2011 Aug 11.

8.

Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors.

Jarajapu YP, Bhatwadekar AD, Caballero S, Hazra S, Shenoy V, Medina R, Kent D, Stitt AW, Thut C, Finney EM, Raizada MK, Grant MB.

Diabetes. 2013 Apr;62(4):1258-69. doi: 10.2337/db12-0808. Epub 2012 Dec 10.

9.

Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.

Liu X, Li Y, Liu Y, Luo Y, Wang D, Annex BH, Goldschmidt-Clermont PJ.

Am J Pathol. 2010 Jan;176(1):504-15. doi: 10.2353/ajpath.2010.081152. Epub 2009 Nov 30.

10.

Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.

Segal MS, Shah R, Afzal A, Perrault CM, Chang K, Schuler A, Beem E, Shaw LC, Li Calzi S, Harrison JK, Tran-Son-Tay R, Grant MB.

Diabetes. 2006 Jan;55(1):102-9.

11.

Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization.

O E, Lee BH, Ahn HY, Shin JC, Kim HK, Kim M, Park IY, Park YG, Joe YA.

FASEB J. 2011 Jan;25(1):159-69. doi: 10.1096/fj.10-162040. Epub 2010 Sep 17.

PMID:
20852063
12.

Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability.

Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, Lin FY, Sata M, Chen JW, Lin SJ.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):869-77. doi: 10.1161/ATVBAHA.109.200618. Epub 2010 Jan 21.

13.

Circulating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injury.

Caballero S, Hazra S, Bhatwadekar A, Li Calzi S, Paradiso LJ, Miller LP, Chang LJ, Kern TS, Grant MB.

Invest Ophthalmol Vis Sci. 2013 Apr 26;54(4):3000-9. doi: 10.1167/iovs.12-10280.

14.

Human umbilical cord blood-derived CD34-positive endothelial progenitor cells stimulate osteoblastic differentiation of cultured human periosteal-derived osteoblasts.

Lee JH, Hah YS, Cho HY, Kim JH, Oh SH, Park BW, Kang YH, Choi MJ, Shin JK, Rho GJ, Jeon RH, Lee HC, Kim GC, Kim UK, Kim JR, Lee CI, Byun JH.

Tissue Eng Part A. 2014 Mar;20(5-6):940-53. doi: 10.1089/ten.TEA.2013.0329. Epub 2013 Dec 3.

PMID:
24168264
15.

Chronic endurance exercise affects paracrine action of CD31+ and CD34+ cells on endothelial tube formation.

Landers-Ramos RQ, Sapp RM, Jenkins NT, Murphy AE, Cancre L, Chin ER, Spangenburg EE, Hagberg JM.

Am J Physiol Heart Circ Physiol. 2015 Aug 1;309(3):H407-20. doi: 10.1152/ajpheart.00123.2015. Epub 2015 Jun 8.

16.

Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress.

Zhao CT, Wang M, Siu CW, Hou YL, Wang T, Tse HF, Yiu KH.

Cardiovasc Diabetol. 2012 Dec 5;11:147. doi: 10.1186/1475-2840-11-147.

17.

Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells.

Ho JC, Lai WH, Li MF, Au KW, Yip MC, Wong NL, Ng ES, Lam FF, Siu CW, Tse HF.

Diabetes Metab Res Rev. 2012 Jul;28(5):462-73. doi: 10.1002/dmrr.2304. Epub 2012 Apr 10.

PMID:
22492468
18.

Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner.

Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ.

Blood. 2001 May 15;97(10):3075-85.

19.

Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy.

Tan K, Lessieur E, Cutler A, Nerone P, Vasanji A, Asosingh K, Erzurum S, Anand-Apte B.

Exp Eye Res. 2010 Aug;91(2):229-37. doi: 10.1016/j.exer.2010.05.012. Epub 2010 May 21.

20.

Scaling up the ex vivo expansion of human circulating CD34(+)progenitor cells with upregulation of angiogenic and anti-inflammatory potential.

Mata MF, Lopes JP, Ishikawa M, Alaiti MA, Cabral JM, da Silva CL, Costa MA.

Cytotherapy. 2015 Dec;17(12):1777-84. doi: 10.1016/j.jcyt.2015.09.003. Epub 2015 Oct 21.

PMID:
26475753

Supplemental Content

Support Center